icatibant acetate

icatibant acetate (ICATIBANT ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: subcutaneous. Current US regulatory status: approved.

ICATIBANT ACETATE is a marketed brand name for icatibant acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

icatibant acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.